The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism

Background and objectives: Cinacalcet, a novel calcimimetic, targets the calcium-sensing receptor to lower parathyroid hormone (PTH), calcium, and phosphorus levels in dialysis patients with secondary hyperparathyroidism (SHPT). This study compared the efficacy of a cinacalcet-based regimen with unr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Messa, Piergiorgio, Macário, Fernando, Yaqoob, Magdi, Bouman, Koen, Braun, Johann, von Albertini, Beat, Brink, Hans, Maduell, Francisco, Graf, Helmut, Frazão, João M., Bos, Willem Jan, Torregrosa, Vicente, Saha, Heikki, Reichel, Helmut, Wilkie, Martin, Zani, Valter J., Molemans, Bart, Carter, Dave, Locatelli, Francesco
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Nephrology 2008
Aiheet:
Clinical Nephrology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2390975/
https://ncbi.nlm.nih.gov/pubmed/18178780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03591006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia